Knee Osteoarthriis and Oxidative Stress Clinical Trial
Official title:
Aerobic Exercise and Knee Osteoarthritis
| Verified date | April 2019 |
| Source | Mansoura University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Background: Obesity and degenerative joint disease are typically concomitant . Each are in
the course of aerobic focus and excited inflammatory response. Exercise is taken into account
a considerable treatment in rehabilitation of each conditions. nevertheless most of
literature reported the good thing about regular exercise, whereas there's dearth regarding
the consequence of base hit low to centrist usage session .
Objective:Hence, this report aimed to analyze the attainable effects of a single bout of
moderate excercise in obese patients with KOA.
Methods:Thirty four rotund OA untrained semantic role and thirty age and sex matched healthy
controls were registered during this sketch . OA patients were allotted to single session of
low to moderate exercise on treadmill whereas controls remained unexercised. Perceived pain,
GR activity, IL-6 , CRP, fasting blood glucose and lipid profile were assessed at baseline ,
once exercise and 24h after. Meanwhile, WOMAC score determined at baseline and once 24h.
| Status | Completed |
| Enrollment | 34 |
| Est. completion date | October 1, 2019 |
| Est. primary completion date | September 1, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 40 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - : knee OA with obesity; sedentary with no previous education ; ability to understand and follow commands; and ability to walk independently. Exclusion Criteria: - Medical conditions contraindicating moderate aerobic exercising (as determined through prescreening questions, i.e., cardiac or coronary artery disease as ischemic cardiomyopathy , chronic lung disease, asthma, uncontrolled hypertension), inability to exercise via treadmill(i.e. no neuromuscular or lower extremity conditions or any other medical contraindication that could prevent them from floor walking as upset affecting movement of the pelvic arch or pace , story of previous hip or knee operating room ,periarticular fractures, or lower limb injuries).History of recent reefer transmission or acute joint lighting .History of recent joint injection (steroid, hyaluronic acid , etc.) within 6 calendar week of study. Ingestion of antioxidant supplementation and the use of psychotropic agents. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Reham Magdy Shaat | Mansoura | Dakahlia Provence |
| Lead Sponsor | Collaborator |
|---|---|
| Mansoura University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | change in degree of pain from base line | 1-Pain Visual Analogue Scale: The VAS-pain score is composed of a continuous horizontal line. This line is 100 mm in length. To measure the intensity of pain, the score is anchored by (0 score = no pain) at one end and (100 score = worst imaginable pain) on the other end. The patient places a mark to the VAS line at the point which represents the intensity of his pain(1 | assessed immediately before excercise, 10 minutes after excercise and 24 hours after excercise | |
| Primary | CHange in function from base line | Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores of the OA patients were collected (10). Scores from the Western Ontario and Mc-Master University (WOMAC) OA index were used to assess pain, stiffness and function in OA patients [11]. Total WOMAC is the sum of 3 subscales scores. High WOMAC score indicates more pain and stiffness and severe functional limitation. |
Assessed before excercise immediately,10 minutes after, excercise,24 hours after excercise | |
| Secondary | CHANGE INserum IL6 FROM BASE LINE, | Serum concentrations of IL-6 were determined using sandwich high sensitivity ELISA kit for quantitative detection of human IL-6 according to manufacturer's protocol (Boster Immunoleader by Boster Biological Technology Co. Inc.) | assessed immediately before excercise, 10 minutesafter excercise,and 24 hours after excercise | |
| Secondary | change in serum C REACTIVE PROTEIN from base line | Detection of serum CRP was performed by Solid Phase Sandwich ELISA according to manufacturer's instructions (Quantikine Human CRP Immunoassay, R&D systems) | assessed immediately before excercise, 10 minutesafter excercise,and 24 hours after excercise | |
| Secondary | change inSERUM LIPID PROFILE from base line | Blood macromolecule profiles, together with total cholesterol (TC), HDL cholesterol (HDL-C), calculated LDL cholesterol(LDL-C), and triglycerides (TG) concentrations were determined by protein assays., | assessed immediately before excercise, 10 minutesafter excercise,and 24 hours after excercise | |
| Secondary | change in serum Glutathione reductase assay: from base line | Spectrophotometric determination of GR activity in the serum was measured as described by Calberg and Mannervic (14) using commercially available Glutathione Reductase Assay Kit(Sigma chemical company, St Louis, Missouri, USA). Glutathione reductase catalyzes the reduction of GSSG by oxidizing NADPH to NADP+. The decrease in absorbance was measured at 340. | assessed immediately before excercise, 10 minutesafter excercise,and 24 hours after excercise |